Practice Guideline Update
Chronic hepatitis B: Update 2009†
Potential conflict of interest: A. S. Lok receives research support from Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Novartis, Roche, Schering, and Innogenetics, and is an advisor/consultant for Bristol-Myers Squibb, Gilead, and Roche. B. J. McMahon's spouse has 100 shares of GlaxoSmithKline in her IRA.
No abstract is available for this article.